320 related articles for article (PubMed ID: 11839555)
1. Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhao J; Shi W; Wang YL; Chen H; Bringas P; Datto MB; Frederick JP; Wang XF; Warburton D
Am J Physiol Lung Cell Mol Physiol; 2002 Mar; 282(3):L585-93. PubMed ID: 11839555
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-beta signaling.
Zhao Y; Geverd DA
Biochem Biophys Res Commun; 2002 Jun; 294(2):319-23. PubMed ID: 12051713
[TBL] [Abstract][Full Text] [Related]
3. Megakaryoblastic leukemia-1 is required for the development of bleomycin-induced pulmonary fibrosis.
Bernau K; Ngam C; Torr EE; Acton B; Kach J; Dulin NO; Sandbo N
Respir Res; 2015 Mar; 16(1):45. PubMed ID: 25885656
[TBL] [Abstract][Full Text] [Related]
4. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.
Bonniaud P; Kolb M; Galt T; Robertson J; Robbins C; Stampfli M; Lavery C; Margetts PJ; Roberts AB; Gauldie J
J Immunol; 2004 Aug; 173(3):2099-108. PubMed ID: 15265946
[TBL] [Abstract][Full Text] [Related]
5. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
Li YJ; Azuma A; Usuki J; Abe S; Matsuda K; Sunazuka T; Shimizu T; Hirata Y; Inagaki H; Kawada T; Takahashi S; Kudoh S; Omura S
Respir Res; 2006 Jan; 7(1):16. PubMed ID: 16438734
[TBL] [Abstract][Full Text] [Related]
6. SIS3, a specific inhibitor of smad3, attenuates bleomycin-induced pulmonary fibrosis in mice.
Shou J; Cao J; Zhang S; Sun R; Zhao M; Chen K; Su SB; Yang J; Yang T
Biochem Biophys Res Commun; 2018 Sep; 503(2):757-762. PubMed ID: 29913150
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
[TBL] [Abstract][Full Text] [Related]
8. Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma.
Lakos G; Takagawa S; Chen SJ; Ferreira AM; Han G; Masuda K; Wang XJ; DiPietro LA; Varga J
Am J Pathol; 2004 Jul; 165(1):203-17. PubMed ID: 15215176
[TBL] [Abstract][Full Text] [Related]
9. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression.
Li Y; Sun Y; Wu N; Ma H
Am J Physiol Cell Physiol; 2022 Jan; 322(1):C63-C72. PubMed ID: 34852209
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice.
Madtes DK; Elston AL; Hackman RC; Dunn AR; Clark JG
Am J Respir Cell Mol Biol; 1999 May; 20(5):924-34. PubMed ID: 10226062
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
[TBL] [Abstract][Full Text] [Related]
12. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
13. Cthrc1 lowers pulmonary collagen associated with bleomycin-induced fibrosis and protects lung function.
Binks AP; Beyer M; Miller R; LeClair RJ
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28292882
[TBL] [Abstract][Full Text] [Related]
14. ERK5 inhibition ameliorates pulmonary fibrosis via regulating Smad3 acetylation.
Kim S; Lim JH; Woo CH
Am J Pathol; 2013 Dec; 183(6):1758-1768. PubMed ID: 24095924
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
16. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
17. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
[TBL] [Abstract][Full Text] [Related]
18. Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway.
Zhao K; Nie H; Tang Z; Chen G; Huang J
Aging (Albany NY); 2023 Oct; 15(19):10524-10539. PubMed ID: 37815883
[TBL] [Abstract][Full Text] [Related]
19. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis.
Bonniaud P; Margetts PJ; Ask K; Flanders K; Gauldie J; Kolb M
J Immunol; 2005 Oct; 175(8):5390-5. PubMed ID: 16210645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
